Lumiradx Stock Annual Yield
LMDXDelisted Stock | USD 0.42 0.02 4.55% |
LumiraDx fundamentals help investors to digest information that contributes to LumiraDx's financial success or failures. It also enables traders to predict the movement of LumiraDx Stock. The fundamental analysis module provides a way to measure LumiraDx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LumiraDx stock.
LumiraDx |
LumiraDx Company Annual Yield Analysis
LumiraDx's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, LumiraDx has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
LumiraDx Fundamentals
Return On Equity | -15.64 | |||
Return On Asset | -0.28 | |||
Profit Margin | (2.67) % | |||
Operating Margin | (2.31) % | |||
Current Valuation | 440.16 M | |||
Shares Outstanding | 161.02 M | |||
Shares Owned By Insiders | 55.41 % | |||
Shares Owned By Institutions | 25.26 % | |||
Number Of Shares Shorted | 1.43 M | |||
Price To Earning | 13.70 X | |||
Price To Book | 18.28 X | |||
Price To Sales | 1.97 X | |||
Revenue | 254.48 M | |||
Gross Profit | 61.02 M | |||
EBITDA | (273.54 M) | |||
Net Income | (449.19 M) | |||
Cash And Equivalents | 106.45 M | |||
Cash Per Share | 0.42 X | |||
Total Debt | 401.25 M | |||
Current Ratio | 2.76 X | |||
Book Value Per Share | (0.67) X | |||
Cash Flow From Operations | (162.11 M) | |||
Short Ratio | 0.09 X | |||
Earnings Per Share | (1.08) X | |||
Target Price | 0.65 | |||
Number Of Employees | 1.21 K | |||
Beta | 1.71 | |||
Market Capitalization | 249.63 M | |||
Total Asset | 441.01 M | |||
Retained Earnings | (1.09 B) | |||
Working Capital | 179.82 M | |||
Net Asset | 441.01 M |
About LumiraDx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LumiraDx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LumiraDx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LumiraDx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |